Your browser doesn't support javascript.
loading
Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study.
Lee, Seung-Hwan; Yoon, Jae-Ho; Min, Gi June; Park, Sung-Soo; Park, Silvia; Lee, Sung-Eun; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Lee, Jong Wook; Lee, Seok.
Afiliação
  • Lee SH; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Yoon JH; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
  • Min GJ; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park SS; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
  • Park S; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee SE; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
  • Cho BS; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Eom KS; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
  • Kim YJ; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim HJ; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
  • Min CK; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Cho SG; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
  • Lee JW; College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee S; Department of Hematology, Seoul St. Mary's Hospital, Catholic Hematology Hospital and Leukemia Research Institute, Seoul, Republic of Korea.
Int J Hematol ; 115(1): 135-139, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34617186
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Homólogo / Anticorpos Biespecíficos / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia Mieloide Crônica Atípica BCR-ABL Negativa / Antineoplásicos Imunológicos / Inotuzumab Ozogamicina Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Hematol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Homólogo / Anticorpos Biespecíficos / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia Mieloide Crônica Atípica BCR-ABL Negativa / Antineoplásicos Imunológicos / Inotuzumab Ozogamicina Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Hematol Ano de publicação: 2022 Tipo de documento: Article